The recall involves defective Yaz Plus packs containing only four hormone tablets instead of 24, compromising their contraceptive effectiveness.
A limited number of defective packs were found in a retail pharmacy.
Some packs have 24 light orange hormone-free and four pink film-coated hormone tablets instead of 24 pink film-coated hormone tablets and four light orange hormone-free tablets.
Eric Chauke, regulatory affairs head at Bayer, has urged wholesalers, hospitals, retail pharmacy outlets, doctors, nurses, patients and customers to return all stocks of the batch WEW96J - expiry date: 03/2026 to DSV Healthcare or the wholesaler/distributor from where they were purchased, for credit.
"This is a Class II Type A recall which is intended for medicines that possibly could cause temporary or medically reversible adverse health problems or mistreatment," Chauke said.
